Blog - Page 2 of 5740 - QualityStocks

FridaySep 18, 2026 9:00 am

SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Tests Confirm Positioning Technology Works Despite Zero Visual Input

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. Recent tests conducted by SPARC AI matter because vision-dependent navigation is one of the most common alternatives to GPS currently in use. The company’s Overwatch platform enables a drone to send the sensor and telemetry data it generates to SPARC AI's servers through an API. The vision-free approach also shapes how Overwatch fits into a drone's existing setup. Most technologies built to help drones navigate without GPS still lean heavily on cameras, matching what the aircraft sees against preloaded maps or terrain imagery. That…

FridaySep 18, 2026 9:00 am

QualityStocksNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Engages Kyndryl to Develop Commercialization Strategy for MAXX LEMI

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) has engaged Kyndryl to develop a comprehensive commercialization strategy and go-to-market plan for MAXX LEMI, its proprietary AI-assisted Large Earth Model Integration platform for Natural Hydrogen exploration. Kyndryl Consult will conduct a technology review, market and competitive analysis and business model assessment, culminating in strategic recommendations for potential commercialization pathways. The approximately nine-week engagement will also assess opportunities to position and scale MAXX LEMI for future growth and market adoption. MAXX LEMI integrates proprietary data…

ThursdaySep 17, 2026 3:43 pm

QualityStocksNewsBreaks – Frontieras North America Inc. Advances Coal-to-Fuels FASForm(TM) Technology

Frontieras is positioning its patented FASForm(TM) technology as a way to strengthen U.S. energy and industrial supply-chain resilience by converting domestically sourced coal into diesel, naphtha, jet fuel, hydrogen, fertilizer, sulfuric acid, and FASCarbon(TM). Frontieras’ closed-loop process captures and repurposes byproducts while producing multiple commercial outputs from a single coal input. The company has begun moving from development toward commercialization with an approximately $850 million facility in Mason County, West Virginia, designed to process 7,500 tons of coal per day and create more than 2,000 construction jobs and 200 permanent positions. To view the article, visit https://ibn.fm/tG5cQ About Frontieras North America Inc. …

ThursdaySep 17, 2026 3:08 pm

QualityStocksNewsBreaks – SS Innovations International Inc. (NASDAQ: SSII) Positions SSi Mantra Amidst Expanding MedTech Market

SS Innovations International (NASDAQ: SSII) is eying opportunity as India seeks to grow domestic manufacturing and reduce reliance on imported medical technology. The market is projected to increase from $15.2 billion in 2025 to $50.1 billion by 2030, while government initiatives aim to strengthen the medical-device manufacturing ecosystem and increase its global market share. SS Innovations already has an established base with its proprietary SSi Mantra surgical robotic system, reporting 224 installations across 12 countries by June 30, 2026, with those systems used in more than 12,000 surgeries. The company also reported strong first-half 2026 financials, including 65.6% year-over-year revenue…

ThursdaySep 17, 2026 2:32 pm

QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Moves GelrinC Into Pivotal Stage of Development

Regentis Biomaterials (NYSE American: RGNT) was featured in a recent article that discussed its efforts to advance GelrinC, an off-the-shelf hydrogel implant designed to support the body’s natural regeneration of damaged knee cartilage. Delivered as a liquid and cured in place with UV light, GelrinC forms a temporary scaffold that gradually degrades over roughly six to nine months, creating an environment intended to support the development of new cartilage without requiring cell harvesting or laboratory expansion. The company cites encouraging Phase 2 data from 56 patients, including improvements in pain and function through four years of follow-up, and says imaging has…

ThursdaySep 17, 2026 11:58 am

QualityStocksNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Forms TechForce Advanced Manufacturing to Pursue Semiconductor Equipment Partnership

Nightfood Holdings (OTCQB: NGTF), doing business as TechForce Robotics, announced the formation of TechForce Advanced Manufacturing Inc., a Nevada corporation established to pursue an advanced-manufacturing partnership with JUN LONG MACHINE INDUSTRIAL CO., LTD. The planned venture is intended to be owned 51% by Nightfood and 49% by JUN LONG, with the parties anticipating a definitive agreement within the next several weeks. TechForce Advanced Manufacturing plans to expand production of an automated Wafer Sorter and Automated Optical Inspection ("AOI") system for 8-inch and 12-inch silicon wafers. JUN LONG currently holds customer purchase orders that the venture expects to begin fulfilling following completion of the definitive agreement, supporting a target of beginning production and generating…

ThursdaySep 17, 2026 11:40 am

QualityStocksNewsBreaks – Lantern Pharma (NASDAQ: LTRN) to Host Webinar on Open-Medicine AI Platform, Business Model and Development Roadmap

Lantern Pharma (NASDAQ: LTRN), a clinical-stage, AI-native biopharma company using artificial intelligence and genomic data to develop precision oncology therapies, announced it will host a live webinar Sept. 23 at 12:30 p.m. Eastern to present the business model, development roadmap and value proposition of Open-Medicine AI ("OMAI"), its wholly owned subsidiary developing a multi-agentic AI platform for end-to-end therapeutic development. The session, led by Panna Sharma, founder and CEO of Open-Medicine AI, will cover OMAI platform architecture, expansion beyond rare cancers into additional disease categories and therapeutic modalities and its planned subscription and enterprise licensing business model. To view the full press release, visit https://ibn.fm/gGQBc…

ThursdaySep 17, 2026 11:31 am

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Announces that Rodman & Renshaw Initiates Coverage with Buy Rating, $8 Price Target

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM), a biopharmaceutical company developing treatments for neurodegenerative and metabolic disorders and alcohol misuse disorders, announced that Rodman & Renshaw initiated coverage of the company with a Buy rating and a $8 price target. The research report was led by Michael G. King Jr., director of research and senior biotechnology analyst at Rodman & Renshaw. Quantum BioPharma said the coverage is unpaid and that it provided no consideration or fees for the report. To view the full press release, visit https://ibn.fm/OC9TG About Quantum BioPharma Ltd. Quantum is a biopharmaceutical company dedicated to building a…

ThursdaySep 17, 2026 11:20 am

QualityStocksNewsBreaks – VolitionRx (NYSE American: VNRX) Joins €6.3 Million French Government-Funded DETECSEPS Sepsis Project

VolitionRx Limited (NYSE American: VNRX) announced the official launch of the DETECSEPS project for the early detection of sepsis as part of the DETECSEPS Consortium, which is receiving €6.3 million, or approximately $7.3 million, in French government funding. The project is an initiative of IHU SEPSIS, coordinated and sponsored by Assistance Publique - Hôpitaux de Paris in partnership with Hospices Civils de Lyon, IDS France and Volition. Volition will provide the project’s sole biomarker, Nu.Q NETs, while IDS France will provide its automated analyzer to measure the biomarker. DETECSEPS will evaluate an early detection approach combining a routinely used clinical score with Volition’s Nu.Q NETs H3.1 blood…

ThursdaySep 17, 2026 10:55 am

QualityStocksNewsBreaks – Silynxcom Ltd. (NYSE American: SYNX) Receives Two Consecutive Orders Totaling Approximately $400,000 for CLARUS In-Ear Headset Systems

Silynxcom (NYSE American: SYNX), a manufacturer and developer of ruggedized tactical communication headset devices and other communication accessories, announced it has received two consecutive purchase orders totaling approximately $400,000 from a leading global defense company for its CLARUS In-Ear Headset system family of products. The systems are designated for a European army, with Silynxcom saying the orders represent a further step in its expanding presence across European markets. To view the full press release, visit https://ibn.fm/AA79G About Silynxcom Ltd. Silynxcom develops, manufactures and sells ruggedized tactical protective and communication headset devices, along with related communication accessories, that have been field-tested…

Site Search

Company Search